Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
Open-market buys, last 90 days
$49,999
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Exton Michael +$50K Chief Executive Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-02-28 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Exercise or conversion · Restricted Stock Units −9,555 0
2021-02-28 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Exercise or conversion · Restricted Stock Units −25,290 25,290
2021-02-28 WADE JEFFREY L EVP, Corp Adm Affairs and CFO Exercise or conversion · Restricted Stock Units −30,467 60,933
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +2,990 72,334
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +9,727 82,061
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +26,600 108,661
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion +28,690 137,351
2021-02-28 TYLE PRAVEEN EVP, R&D Shares withheld for taxes −16,560 $7.19 $119K 120,791
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −2,990 0
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −9,727 0
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −26,600 26,600
2021-02-28 TYLE PRAVEEN EVP, R&D Exercise or conversion · Restricted Stock Units −28,690 57,380
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +1,270 66,397
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +4,213 70,610
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +8,836 79,446
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion +13,997 93,443
2021-02-28 Tessmer James F VP, Finance & Accounting Shares withheld for taxes −10,765 $7.19 $77K 82,678
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −1,270 0
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −4,213 0
2021-02-28 Tessmer James F VP, Finance & Accounting Exercise or conversion · Restricted Stock Units −8,836 8,837

Page 29 of 51 · 1,001 trades